Relapsed/Refractory Multiple Myeloma Patients. a Multicenter Retrospective Analysis of Eligibility Criteria for CAR-T Cell Therapy

被引：0
|
作者：
Fazio, Francesca [1 ]
Di Rocco, Alice [1 ]
Za, Tommaso [2 ]
Tomarchio, Valeria [3 ]
Rago, Angela [4 ]
Piciocchi, Alfonso [5 ]
di Toritto, Tommaso Caravita
Annibali, Ombretta [3 ]
De Stefano, Valerio [2 ]
Foa, Robin [1 ]
Martelli, Maurizio [1 ]
Petrucci, Maria Teresa [1 ]
机构：
[1] Sapienza Univ Rome, Dept Translat & Precis Med, Azienda Osped Policlin Umberto 1, Hematol, Rome, Italy
[2] Catholic Univ, Sect Hematol, Dept Radiol & Hematol Sci, Fdn Policlin A Gemelli, Rome, Italy
[3] Univ Campus Bio Medico, Hematol Unit, Stem Cell Transplantat, Rome, Italy
[4] UOSD Ematol ASL Roma 1, Rome, Italy
[5] Italian Grp Adult Hematol Dis GIMEMA, Rome, Italy
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149547
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3755
引用
收藏
页码：3755 / +
页数：5
相关论文
共 50 条
  • [31] Overview of anti-BCMA CAR-T immunotherapy for multiple myeloma and relapsed/refractory multiple myeloma
    Feng, Deming
    Sun, Jian
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (02)
  • [32] CD19 CAR T-Cell Therapy in Patients with Relapse/Refractory DLBCL: Retrospective Analysis of the Eligibility Criteria
    Paillassa, Jerome
    Di Blasi, Roberta
    Chevret, Sylvie
    Bernard, Sophie
    Darmon, Michael
    Meignin, Veronique
    Deau-Fischer, Benedicte
    Camus, Vincent
    Casasnovas, Rene-Olivier
    Cartron, Guillaume
    Chaoui, Driss
    Delwail, Vincent
    Feugier, Pierre
    Fornecker, Luc Mathieu
    Gyan, Emmanuel
    Haioun, Corinne
    Kuhnowski, Frederique
    Malfuson, Jean Valere
    Marolleau, Jean-Pierre
    Morel, Veronique
    Damaj, Gandhi
    Quinquenel, Anne
    Rigaudeau, Sophie
    Salanoubat, Celia
    Salmeron, Geraldine
    Sibon, David
    Azoulay, Elie
    Berquier, Maxime
    Thieblemont, Catherine
    BLOOD, 2019, 134
  • [33] A new CAR-T cell therapy for multiple myeloma
    Hosen, Naoki
    CANCER SCIENCE, 2022, 113 : 644 - 644
  • [34] A Preliminary Study on the Safety and Efficacy of a Novel Human BCMATargeting CAR-T Therapy in Patients with Relapsed/Refractory Multiple Myeloma
    Wang, Yi
    Gao, Ying
    Wang, Hui
    Zhang, Ding
    Zheng, Yan
    Hu, Xingxing
    Gao, Qiuying
    Niu, Ben
    Zhang, Hong
    Zhou, Wei
    Zhang, Weihua
    Ru, Xingli
    Wang, Fangyuan
    BLOOD, 2021, 138
  • [35] BCMA CAR-T therapy combined with pomalidomide is a safe and effective treatment for relapsed/refractory multiple myeloma
    Yan, Yuhan
    Tu, Yixuan
    Cheng, Qian
    Zhang, Jian
    Wang, Erhua
    Deng, Zuqun
    Yu, Yan
    Wang, Liwen
    Liu, Rui
    Chu, Ling
    Kang, Liqing
    Liu, Jing
    Li, Xin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [36] GPRC5D-targeted CAR-T cell therapy in patients with relapsed or refractory multiple myeloma progressing after or refractory to BCMA CAR-T cell therapy: updated eesults from a phase 2 clinical trial
    Xia, Jieyun
    Li, Zhenyu
    Li, Hujun
    Yan, Zhiling
    Xu, Mengdi
    Xu, Kailin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S5 - S6
  • [37] Tisagenlecleucel: CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma
    Saha, Aditi
    Jhaveri, Khushali
    Sarfraz, Humaira
    Chavez, Julio C.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, : 869 - 876
  • [38] Total Car-T Cost of Care Beyond the Price of Car-T Cell Therapy in Patients with Multiple Myeloma
    Jagannath, Sundar
    Joseph, Nedra
    Crivera, Concetta
    Jackson, Carolyn C.
    Valluri, Satish
    Cost, Patricia
    Phelps, Hilary
    Slowik, Rafal
    Klein, Timothy
    Yu, Xueting
    Smolen, Lee
    Cohen, Adam D.
    BLOOD, 2021, 138
  • [39] Mechanisms and salvage treatments in patients with multiple myeloma relapsed post-BCMA CAR-T cell therapy
    Fu, Bingjie
    Liu, Rui
    Gao, Gongzhizi
    Lin, Zujie
    He, Aili
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [40] Tisagenlecleucel: CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma
    Saha, Aditi
    Jhaveri, Khushali
    Sarfraz, Humaira
    Chavez, Julio C.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023,
12345